Invivyd (IVVD) Cash from Investing Activities (2021 - 2025)

Invivyd (IVVD) posted Cash from Investing Activities of -$11000.0 for Q2 2025, up 92.36% on a QoQ basis from -$144000.0 in Q1 2025.

Invivyd (IVVD) Cash from Investing Activities (2021 - 2025) Analysis & Trends

Invivyd's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$11000.0 for Q2 2025.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to -$11000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$155000.0 (down 10.71% YoY) and the FY2025 annual result came in at -$155000.0, down 10.71% from the prior year.
  • Cash from Investing Activities was -$11000.0 for Q2 2025 at Invivyd, up from -$144000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $137.9 million in Q4 2021 and bottomed at -$188.6 million in Q3 2021.
  • A 5-year average of -$65933.3 and a median of -$5000.0 in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 200.65% — and 2023, when it soared 191835.29%.
  • Invivyd's Cash from Investing Activities stood at $137.9 million in 2021, then plunged by 200.65% to -$138.8 million in 2022, then jumped by 156.13% to $77.9 million in 2023, then slumped by 99.99% to $5000.0 in 2024, then tumbled by 320.0% to -$11000.0 in 2025.
  • Business Quant data shows IVVD's Cash from Investing Activities at -$11000.0 in Q2 2025, -$144000.0 in Q1 2025, and $5000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 67,132.22 Bn 67,131.94 Bn - -
2 Nanobiotix 1,910.87 Bn 1,910.81 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 471.60 Bn 466.80 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.71 Bn 114.46 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.83 Bn 61.07 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.74 Bn 62.74 Bn - -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.33 Bn 34.32 Bn 959.66 Mn -25.54 Mn
10 Invivyd 104.89 Mn -121.79 Mn 16.07 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 -11,000.00
Jun 30, 2025 -11,000.00
Mar 31, 2025 -144,000.00
Mar 31, 2025 -144,000.00
Dec 31, 2024 5,000.00
Dec 31, 2024 5,000.00
Sep 30, 2024 -5,000.00
Sep 30, 2024 -5,000.00
Mar 31, 2024 -140,000.00
Mar 31, 2024 -140,000.00
Dec 31, 2023 77.92 Mn
Dec 31, 2023 77.92 Mn
Sep 30, 2023 95.14 Mn
Sep 30, 2023 95.14 Mn
Jun 30, 2023 32.60 Mn
Jun 30, 2023 32.60 Mn
Mar 31, 2023 75.04 Mn
Mar 31, 2023 75.04 Mn
Dec 31, 2022 -138.81 Mn
Dec 31, 2022 -138.81 Mn